Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07527130 · ClinicalTrials.gov registry record
C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome
A clinical trial, sponsored by Mayo Clinic.
- Not yet
- Registry status
- 10
- Enrollment target
NCT07527130: Clinical Trial study, sponsored by Mayo Clinic.
NCT07527130 is a clinical trial that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07527130 has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.
Interventions
- DRUG C11 ER176 Tracer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-05 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07527130
The ClinicalTrials.gov registry entry for NCT07527130 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which C11 ER176 Tracer is the first listed.
NCT07527130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07527130 about?
NCT07527130 is a clinical study titled "C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome". The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.
What is the current status of trial NCT07527130?
This trial is currently not yet recruiting. The enrollment target is 10 participants. The study started on 2026-05. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07527130?
The interventions under investigation include: C11 ER176 Tracer (DRUG).
Who is sponsoring clinical trial NCT07527130?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.